Calendar
Top-down
A look at earnings from the view of macro-economists and market technicians
Market Overview
Heat Map
Sentiment
Technicals
Retail Sales
Pricing
Manu-facturing
Economic Cycle
Bottom-up
A bottom-up view of earnings from professional equity analysts
Earnings Highlights
Date Trades
Earnings News
Pivots
Earnings Cycle
Sector Analysis
Investor
Trader
Support
Documentation, research, and support for the information provided
Indicators
Results
About Us
Library
Contact Us
Plays
Score
Grade
Sign In
Sign In
or
Register
Forgot Password?
OR
Sign in using:
Don't have an account?
Register
QGEN
$46.37
Qiagen N.V.
($.31)
(.66%)
QGEN
Earnings Whisper ®
N/A
2nd Quarter June 2022
Consensus: $0.45
Revenue: $475.75 Mil
Tuesday
Jul 26
After the close
Score
Grade
Tweet
Share
Watch
Sentiment
Analysts
Sentiment
Analysts
Tweet
Share
Watch
Latest EPS
Tuesday, April 26, 2022
QIAGEN exceeds outlook for Q1 2022, delivers strong 14% CER sales growth from non-COVID products and increases full-year outlook
What do you expect when QGEN reports earnings?
Beat
Meet
Miss
Where is QGEN's stock price going from here?
Up
Flat
Down
Analysts
Score
Grade
Sentiment
Analysts
Pivots
Resistance
$47.52
$47.22
$46.95
$46.65
Support
$46.38
$46.08
$45.81
Tweet
Trends
Short-term Price
Intermediate-term Price
Long-term Price
Investors' Sentiment
Analysts' Sentiment
Earnings Estimates
Growth
Description
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Peers
Biogen
Neurocrine Biosciences
Amgen
Gilead Sciences
Bluebird Bio
Seagen Inc.
BioCryst Pharmaceuticals
Repligen
Novavax
Sangamo Therapeutics
Expectations
›
Qiagen N.V.
